Pihlajalinna Oyj

DB:38P Stock Report

Market Cap: €238.3m

Pihlajalinna Oyj Past Earnings Performance

Past criteria checks 4/6

Pihlajalinna Oyj has been growing earnings at an average annual rate of 9.3%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 9% per year. Pihlajalinna Oyj's return on equity is 8.8%, and it has net margins of 1.8%.

Key information

9.3%

Earnings growth rate

9.3%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate9.0%
Return on equity8.8%
Net Margin1.8%
Next Earnings Update12 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Pihlajalinna Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:38P Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2470613140
30 Jun 2470710140
31 Mar 247167140
31 Dec 237216140
30 Sep 2372610140
30 Jun 2372610210
31 Mar 2371710180
31 Dec 2269110140
30 Sep 2265714200
30 Jun 2263318100
31 Mar 2260221100
31 Dec 2157820100
30 Sep 2156019100
30 Jun 2154317100
31 Mar 2151612100
31 Dec 205099100
30 Sep 20505990
30 Jun 20504390
31 Mar 20519390
31 Dec 19519390
30 Sep 19512280
30 Jun 19505680
31 Mar 19501680
31 Dec 18488380
30 Sep 184693130
30 Jun 184523130
31 Mar 184335130
31 Dec 1742410130
30 Sep 174209140
30 Jun 174149140
31 Mar 174099140
31 Dec 163998140
30 Sep 16358690
30 Jun 16315590
31 Mar 16266290
31 Dec 15213090
30 Sep 15203160
30 Jun 15184060
31 Mar 15165160
31 Dec 14149160
31 Dec 13104440

Quality Earnings: 38P has high quality earnings.

Growing Profit Margin: 38P's current net profit margins (1.8%) are higher than last year (1.4%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 38P's earnings have grown by 9.3% per year over the past 5 years.

Accelerating Growth: 38P's earnings growth over the past year (26.3%) exceeds its 5-year average (9.3% per year).

Earnings vs Industry: 38P earnings growth over the past year (26.3%) did not outperform the Healthcare industry 40.5%.

Return on Equity

High ROE: 38P's Return on Equity (8.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 10:21
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pihlajalinna Oyj is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Iiris ThemanCarnegie Investment Bank AB
Panu LaitinmäkiDanske Bank
Sami SarkamiesDanske Bank